The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
The Long Noncoding RNA HOTAIR Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma Cells via downregualtion of p21WAF1/CIP1 Expression
Open accessAbstract
HOTAIR, a long intervening non-coding RNA (lincRNA), associates with the Polycomb Repressive Complex 2 (PRC2) and is reported to reprogram chromatin organization and promote tumor progression. However, little is known about the roles of this gene in the development of chemoresistance phenotype of lung adenocarcinoma (LAD). Thus, we investigated the involvement of HOTAIR in the resistance of LAD cells to cisplatin. In this study, we show that HOTAIR expression was significantly upregulated in cisplatin-resistant A549/DDP cells compared with in parental A549 cells. Knockdown of HOTAIR by RNA interference could resensitize the responses of A549/DDP cells to cisplatin both in vitro and in vivo. In contrast, overexpression of HOTAIR could decrease the sensitivity of A549 and SPC-A1 cells to cisplatin. We also found that the siRNA/HOTAIR1-mediated chemosensivity enhancement was associated with inhibition of cell proliferation, induction of G0/G1 cell-cycle arrest and apoptosis enhancement through regulation of p21(WAF1/CIP1) (p21) expression. Also, pcDNA/p21or siRNA/p21 could mimic the effects of siRNA/HOTAIR1 or pcDNA/HOTAIR on the sensitivity of LAD cells to cisplatin. Importantly, siRNA/p21 or pcDNA/p21 could partially rescue the effects of siRNA/HOTAIR1 or pcDNA/HOTAIR on both p21 expression and cisplatin sensitivity in LAD cells. Further, HOTAIR was observed to be significantly downregulated in cisplatin-responding LAD tissues, and its expression was inversely correlated with p21 mRNA expression. Taken together, our findings suggest that upregulation of HOTAIR contributes to the cisplatin resistance of LAD cells, at least in part, through the regulation of p21 expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis
Gupta, R. A., Shah, N., Wang, K. C., Kim, J., Horlings, H. M., Wong, D. J., Tsai, M.-C., Hung, T., Argani, P., Rinn, J. L., et al. (2010) · Nature · doi:10.1038/nature08975 · Cited by 5,218
Molecular Mechanisms of Long Noncoding RNAs
Wang, K. C., & Chang, H. Y. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.018 · Cited by 4,396
Khalil, A. M., Guttman, M., Huarte, M., Garber, M., Raj, A., Rivea Morales, D., Thomas, K., Presser, A., Bernstein, B. E., van Oudenaarden, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904715106 · Cited by 2,872
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712
Long noncoding RNAs and human disease
Wapinski, O., & Chang, H. Y. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2011.04.001 · Cited by 1,900
Long noncoding RNAs: past, present, and future
Kung, J. T. Y., Colognori, D., & Lee, J. T. (2013) · Genetics · doi:10.1534/genetics.112.146704 · Cited by 1,874
Ambros, V. (2001) · Cell · doi:10.1016/s0092-8674(01)00616-x · Cited by 1,697
Kogo, R., Shimamura, T., Mimori, K., Kawahara, K., Imoto, S., Sudo, T., Tanaka, F., Shibata, K., Suzuki, A., Komune, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1021 · Cited by 1,238
Shen, D.-W., Pouliot, L. M., Hall, M. D., & Gottesman, M. M. (2012) · Pharmacological Reviews · doi:10.1124/pr.111.005637 · Cited by 955
No-Nonsense Functions for Long Noncoding RNAs
Nagano, T., & Fraser, P. (2011) · Cell · doi:10.1016/j.cell.2011.03.014 · Cited by 878
HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer
Kim, K., Jutooru, I., Chadalapaka, G., Johnson, G., Frank, J., Burghardt, R., Kim, S., & Safe, S. (2013) · Oncogene · doi:10.1038/onc.2012.193 · Cited by 782
Long Intergenic Noncoding RNAs: New Links in Cancer Progression
Tsai, M.-C., Spitale, R. C., & Chang, H. Y. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2483 · Cited by 641
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
Chang, A. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2010.08.022 · Cited by 443
Kaneko, S., Li, G., Son, J., Xu, C.-F., Margueron, R., Neubert, T. A., & Reinberg, D. (2010) · Genes & Development · doi:10.1101/gad.1983810 · Cited by 398
Long noncoding RNA: an emerging paradigm of cancer research
Qiu, M.-T., Hu, J.-W., Yin, R., & Xu, L. (2013) · Tumor Biology · doi:10.1007/s13277-013-0658-6 · Cited by 375
Upregulation of miR-196a and HOTAIR Drive Malignant Character in Gastrointestinal Stromal Tumors
Niinuma, T., Suzuki, H., Nojima, M., Nosho, K., Yamamoto, H., Takamaru, H., Yamamoto, E., Maruyama, R., Nobuoka, T., Miyazaki, Y., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1803 · Cited by 354
Long non-coding RNAs and human disease
Harries, L. W. (2012) · Biochemical Society Transactions · doi:10.1042/bst20120020 · Cited by 336
The role of EZH2 in tumour progression
Chang, C.-J., & Hung, M.-C. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.551 · Cited by 332
Non‐coding RNAs: Meet thy masters
Costa, F. F. (2010) · BioEssays · doi:10.1002/bies.200900112 · Cited by 312
Ma, J., Dong, C., & Ji, C. (2010) · Cancer Gene Therapy · doi:10.1038/cgt.2010.18 · Cited by 303
Long intronic noncoding RNA transcription: Expression noise or expression choice?
Louro, R., Smirnova, A. S., & Verjovski-Almeida, S. (2009) · Genomics · doi:10.1016/j.ygeno.2008.11.009 · Cited by 253
ISHIBASHI, M., KOGO, R., SHIBATA, K., SAWADA, G., TAKAHASHI, Y., KURASHIGE, J., AKIYOSHI, S., SASAKI, S., IWAYA, T., SUDO, T., et al. (2013) · Oncology Reports · doi:10.3892/or.2012.2219 · Cited by 235
Lipovich, L., Johnson, R., & Lin, C.-Y. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.10.001 · Cited by 201
Lu, L., Zhu, G., Zhang, C., Deng, Q., Katsaros, D., Mayne, S. T., Risch, H. A., Mu, L., Canuto, E. M., Gregori, G., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2314-z · Cited by 169
Yi, C., Wang, Q., Wang, L., Huang, Y., Li, L., Liu, L., Zhou, X., Xie, G., Kang, T., Wang, H., et al. (2012) · Oncogene · doi:10.1038/onc.2011.629 · Cited by 157
Romanov, V. S., Поспелов, В. А., & Pospelova, T. V. (2012) · Biochemistry (Moscow) · doi:10.1134/s000629791206003x · Cited by 143
Myeloid malignancies: mutations, models and management
Murati, A., Brecqueville, M., Devillier, R., Mozziconacci, M.-J., Gelsi-Boyer, V., & Birnbaum, D. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-304 · Cited by 139
Epigenomics and Interindividual Differences in Drug Response
Ivanov, M., Kacevska, M., & Ingelman‐Sundberg, M. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.152 · Cited by 139
HOTAIR Lifts Noncoding RNAs to New Levels
Woo, C. J., & Kingston, R. E. (2007) · Cell · doi:10.1016/j.cell.2007.06.014 · Cited by 138
Induction of long intergenic non-coding RNA HOTAIR in lung cancer cells by type I collagen
Zhuang, Y., Wang, X., Nguyen, H. T., Zhuo, Y., Cui, X., Fewell, C., Flemington, E. K., & Shan, B. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-35 · Cited by 126
Lin, J., Huang, S., Wu, S., Ding, J., Zhao, Y., Liang, L., Tian, Q., Zha, R., Zhan, R., & He, X. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr199 · Cited by 118
EZH2: a pivotal regulator in controlling cell differentiation.
Chen, Y.-H., Hung, M., & Li, L. (2012) · Europe PMC (PubMed Central) · Cited by 86
Cao, W., Ribeiro, R. D. O., Liu, D., Saintigny, P., Xia, R., Xue, Y., Lin, R., Mao, L., & Ren, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052984 · Cited by 80
miRNAs as Mediators of Drug Resistance
Haenisch, S., & Cascorbi, I. (2012) · Epigenomics · doi:10.2217/epi.12.39 · Cited by 67
Semaan, A. Y., Qazi, A. M., Seward, S. M., Chamala, S., Bryant, C. S., Kumar, S., Morris, R. T., Steffes, C. P., Bouwman, D. L., Munkarah, A. R., et al. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0547-x · Cited by 59
Inhibition of tumor cell growth by p21WAF1 adenoviral gene transfer in lung cancer.
Joshi, U. S., Chen, Y. Q., Kalemkerian, G. P., Adil, M. R., Kraut, M., & Sarkar, F. H. (1998) · PubMed · Cited by 29
Chen, J., Li, J., Han, Q., Sun, Z., Wang, J., Wang, S., & Zhao, R. C. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.012075 · Cited by 25
Epigenetic Markers and Response to Chemotherapy in Cancer
Strathdee, G. R. (2007) · Disease Markers · doi:10.1155/2007/610815 · Cited by 8
Cited by
LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer
Bhan, A., & Mandal, S. S. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.07.001 · Cited by 456
Functions of lncRNA HOTAIR in lung cancer
Loewen, G., Jayawickramarajah, J., Zhuo, Y., & Shan, B. (2014) · Journal of Hematology & Oncology · doi:10.1186/s13045-014-0090-4 · Cited by 454
HOTAIR: an oncogenic long non-coding RNA in different cancers.
Hajjari, M., & Salavaty, A. (2015) · PubMed · doi:10.7497/j.issn.2095-3941.2015.0006 · Cited by 446
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy
Wang, Z., Zhang, X.-J., Ji, Y.-X., Zhang, P., Deng, K.-Q., Gong, J., Ren, S., Wang, X., Chen, I., Wang, H., et al. (2016) · Nature Medicine · doi:10.1038/nm.4179 · Cited by 386
Self-citationFan, Y., Shen, B., Tan, M., Mu, X., Qin, Y., Zhang, F., & Liu, Y. (2014) · The FEBS Journal · doi:10.1111/febs.12737 · Cited by 370
Metadata
- Authors
- Liu, Z., Sun, M., Lu, K., Liu, J., Zhang, M., Wu, W., De, W., Wang, Z., & Wang, R.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-10-14
- Volume
- 8
- Issue
- 10
- Pages
- e77293
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2113622484
- Cited by
- 309
- References
- 40
- FWCI
- 8.69
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.